Quanterix Corporation Accounts Receivable, Allowance for Credit Loss
Quanterix Corporation (QTRX) had Accounts Receivable, Allowance for Credit Loss of $370.00 thousand as of 2020-12-31, per its 10-K filed 2021-03-05.
Discontinued › Balance Sheet › Assets › Accounts Receivable, after Allowance for Credit Loss
us-gaap:AllowanceForDoubtfulAccountsReceivable · last filed 2021-03-05
- 2020-12-31: Accounts Receivable, Allowance for Credit Loss $370.00K.
- 2019-12-31: Accounts Receivable, Allowance for Credit Loss $162.00K.
- 2018-12-31: Accounts Receivable, Allowance for Credit Loss $36.00K.
| Period end | Accounts Receivable, Allowance for Credit Loss |
|---|---|
| 2020-12-31 | $370.00K 10-K · filed 2021-03-05 |
| 2019-12-31 | $162.00K 10-K · filed 2021-03-05 |
| 2018-12-31 | $36.00K 10-K · filed 2021-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |